BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30409193)

  • 1. Metformin induces apoptosis in mesenchymal stromal cells and dampens their therapeutic efficacy in infarcted myocardium.
    He X; Yao MW; Zhu M; Liang DL; Guo W; Yang Y; Zhao RS; Ren TT; Ao X; Wang W; Zeng CY; Liang HP; Jiang DP; Yu J; Xu X
    Stem Cell Res Ther; 2018 Nov; 9(1):306. PubMed ID: 30409193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin impairs homing ability and efficacy of mesenchymal stem cells for cardiac repair in streptozotocin-induced diabetic cardiomyopathy in rats.
    Ammar HI; Shamseldeen AM; Shoukry HS; Ashour H; Kamar SS; Rashed LA; Fadel M; Srivastava A; Dhingra S
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1290-H1302. PubMed ID: 33513084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mi R -15a/15b Cluster Modulates Survival of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy of Myocardial Infarction.
    Tu Y; Qiu Y; Liu L; Huang T; Tang H; Liu Y; Guo W; Jiang H; Fan Y; Yu B
    J Am Heart Assoc; 2019 Jan; 8(1):e010157. PubMed ID: 30616426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD51 distinguishes a subpopulation of bone marrow mesenchymal stem cells with distinct migratory potential: a novel cell-based strategy to treat acute myocardial infarction in mice.
    Xie DM; Li YL; Li J; Li Q; Lu G; Zhai Y; Zhang J; Huang Z; Gao X
    Stem Cell Res Ther; 2019 Nov; 10(1):331. PubMed ID: 31747966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 12. Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway.
    Zhang Z; Tan Y; Zhu L; Zhang B; Feng P; Gao E; Xu C; Wang X; Yi W; Sun Y
    Life Sci; 2019 Aug; 231():116554. PubMed ID: 31194992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord tissue-derived mesenchymal stromal cells attenuate remodeling after myocardial infarction by proangiogenic, antiapoptotic, and endogenous cell-activation mechanisms.
    Santos Nascimento D; Mosqueira D; Sousa LM; Teixeira M; Filipe M; Resende TP; Araújo AF; Valente M; Almeida J; Martins JP; Santos JM; Bárcia RN; Cruz P; Cruz H; Pinto-do-Ó P
    Stem Cell Res Ther; 2014 Jan; 5(1):5. PubMed ID: 24411922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
    Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
    Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
    Chen R; Cai X; Liu J; Bai B; Li X
    Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes from mesenchymal stem cells overexpressing MIF enhance myocardial repair.
    Liu X; Li X; Zhu W; Zhang Y; Hong Y; Liang X; Fan B; Zhao H; He H; Zhang F
    J Cell Physiol; 2020 Nov; 235(11):8010-8022. PubMed ID: 31960418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
    Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
    Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
    Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
    Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
    Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
    Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.